Literature DB >> 15625297

Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrovascular disease.

Joseph Ngeh1, Colin Goodbourn.   

Abstract

BACKGROUND AND
PURPOSE: Multiple studies have suggested an association between Chlamydia pneumoniae and Mycoplasma pneumoniae infection and cardiovascular disease. We investigated whether the risk of cerebrovascular disease is associated with Legionella pneumophila infection and the aggregate number/infectious burden of these atypical respiratory pathogens.
METHODS: One hundred patients aged >65 years admitted with acute stroke or transient ischemic attack (TIA) and 87 control patients admitted concurrently with acute noncardiopulmonary, noninfective conditions were recruited prospectively. Using enzyme-linked immunosorbent assay (ELISA) kits, we previously reported the seroprevalences of C pneumoniae and M pneumoniae in these patients. We have now determined the seroprevalences of L pneumophila IgG and IgM in this cohort of patients using ELISA.
RESULTS: The seroprevalences of L pneumophila IgG and IgM were 29% (n=91) and 12% (n=81) in the stroke/TIA group and 22% (n=86) and 10% (n=72) in the controls, respectively. Using logistic regression to adjust for age, sex, hypertension, smoking, diabetes, ischemic heart disease, and ischemic ECG, the odds ratios for stroke/TIA in relation to L pneumophila IgG and IgM were 1.52 (95% CI, 0.70 to 3.28; P=0.29) and 1.49 (95% CI, 0.45 to 4.90; P=0.51), respectively. The odds ratios in relation to IgG seropositivity for 1, 2, or 3 atypical respiratory pathogens after adjustment were 3.89 (95% CI, 1.13 to 13.33), 2.00 (95% CI, 0.64 to 6.21), and 6.67 (95% CI, 1.22 to 37.04), respectively (P=0.06).
CONCLUSIONS: L pneumophila seropositivity is not significantly associated with stroke/TIA. However, the risk of stroke/TIA appears to be associated with the aggregate number of chronic infectious burden of atypical respiratory pathogens such as C pneumoniae, M pneumoniae, and L pneumophila.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625297     DOI: 10.1161/01.STR.0000152961.11730.d9

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Mycoplasma pneumoniae and Chlamydia pneumoniae seropositivity in patients with age-related macular degeneration.

Authors:  Burak Turgut; Fatma Uyar; Fulya Ilhan; Tamer Demir; Ulku Celiker
Journal:  J Clin Med Res       Date:  2010-03-31

2.  No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.

Authors:  T W Weiss; H Kvakan; C Kaun; M Prager; W S Speidl; G Zorn; S Pfaffenberger; I Huk; G Maurer; K Huber; J Wojta
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

Review 3.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

4.  Potential association between bacterial infections and ischemic stroke based on fifty case-control studies: A systematic review and meta-analysis.

Authors:  M Keikha; M Karbalaei
Journal:  New Microbes New Infect       Date:  2022-04-15

5.  Infectious burden and risk of stroke: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Pankajavalli Ramakrishnan; Yeseon P Moon; Bernadette Boden-Albala; Khin M Liu; Steve L Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Arch Neurol       Date:  2009-11-09

6.  Exposure to the US Stroke Buckle as a risk factor for cerebrovascular mortality.

Authors:  Ilan Shrira; Nicholas Christenfeld; George Howard
Journal:  Neuroepidemiology       Date:  2008-04-25       Impact factor: 3.282

Review 7.  Infectious burden: a new risk factor and treatment target for atherosclerosis.

Authors:  Mitchell S V Elkind
Journal:  Infect Disord Drug Targets       Date:  2010-04

8.  Identification of an N-terminal 27 kDa fragment of Mycoplasma pneumoniae P116 protein as specific immunogen in M. pneumoniae infections.

Authors:  Irum Tabassum; Rama Chaudhry; Bishwanath Kumar Chourasia; Pawan Malhotra
Journal:  BMC Infect Dis       Date:  2010-12-13       Impact factor: 3.090

9.  Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control study.

Authors:  N K Rai; R Choudhary; R Bhatia; M B Singh; M Tripathi; K Prasad; M V Padma
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

10.  Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay.

Authors:  Wei Li; Yujie Liu; Yun Zhao; Ran Tao; Yonggang Li; Shiqiang Shang
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.